Application of pulsed electric fields for the valorization of platelets with no therapeutic value for transfusion medicine.

Platelets are blood components with high biomedical potential due to their physiological role in wound healing and their rich growth factor content. This paper describes proof-of-concept experiments aimed to produce a new blood-derived product by applying pulsed electric fields (PEF) to platelet concentrates (PC) with no therapeutic value for transfusion medicine. A human platelet concentrate suspension was subjected to a PEF treatment of 1 pulse, 5 kV/cm, for 2 μ s. Release of platelet-derived growth factor (PDGF) from the electroporated platelets was measured by ELISA. Furthermore, the biological activity of the obtained blood-derived product was characterized. Human mesenchymal stem cells (hMSC) were cultured in the presence of the proteins released from the platelets after PEF application and evaluated for their expansion potential. Results show that platelet concentrates subjected to a single PEF treatment can release PDGF to the supernatant. Protein release from the single and transient PEF cycle was confirmed by the expansion of hMSC cultured with a medium supplemented with the platelet releasate obtained from electroporated platelets. These results demonstrate the potential of a new application of PEF for the valorization of PC into a biomedical product with therapeutic value. [ABSTRACT FROM AUTHOR]

Copyright of TECHNOLOGY is the property of World Scientific Publishing Company and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)